Paragon 28 Inc (FNA) Inventory Turnover Ratio, from fourth quarter 2024 to fourth quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Paragon 28 inc   (NYSE: FNA)
 

Paragon 28 Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Paragon 28 Inc 's inventory turnover ratio, the ratio that measures Paragon 28 Inc 's ability to manage its supply chain, sequentially decreased to 0.68 in the fourth quarter 2024, but it does not raise any concerns as Paragon 28 Inc continue to execute well, and the inventory turnover ratio remains above the average. Paragon 28 Inc 's average inventory processing period in the Dec 31 2024 quarter, has increased to 537 days, from 514 days, in the Sep 30 2024 quarter.

Within Healthcare sector 365 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2024, to 1258, from total ranking in the third quarter 2024 at 1827.

FNA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Paragon 28 Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FNA Inventory Turnover Ratio (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Inventory Growth -0.02 % 2.19 % 13.12 % 36.79 % 47.74 %
Y / Y Cost of Sales Growth -13.93 % 60 % 69.34 % 45.97 % 143.64 %
Inventory Turnover Ratio (TTM) 0.68 0.71 0.65 0.6 0.6
FNA's Total Ranking # 1258 # 1827 # 1519 # 1972 # 1592
Average inventory processing period 538 512 559 603 606
Seq. Inventory Growth -6.65 % 0.04 % 1.88 % 5.09 % -4.59 %
Seq. Cost of Sales Growth 25 % 6.67 % 15.38 % -44.05 % 132.36 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 161
Healthcare Sector # 366
Overall Market # 1258

Inventory Turnover Ratio Statistics
High Average Low
0.71 0.6 0.46
(Sep 30 2024)   (Mar 31 2022)



FNA Company Profile >> Back to FNA Efficiency Comparisons >> Compare FNA Inventory Turnover Ratio to its Competitors

Financial Statements
Paragon 28 Inc 's Inventories $ 90 Millions Visit FNA's Balance sheet
Paragon 28 Inc 's Cost of Revenues TTM $ 64 Millions Visit FNA's Income Statement
What are FNA's Sales? Visit FNA's Sales by Segment

Other Inventory Turnover Ratios
Paragon 28 Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
FNA's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for FNA's Competitors
Inventory Turnover Ratio for FNA's Suppliers
Inventory Turnover Ratio for FNA's Customers

You may also want to know
FNA's Sales Growth Rates FNA's Pe Price to earnings ratio FNA's Receivables Turnover Ratio FNA's Stock Quote
FNA's Net Income Growth Rates FNA's Ps Price to Sales ratio FNA's Sales per Employee FNA's Asset Turnover Ratio
FNA's Net Margin FNA's Pb Price to Book ratio FNA's Financial Strength Ratios FNA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2024 Inventories at quarter ending Dec 31 2024
Aditxt Inc   1.95 $ 0.628  Millions$ 0  Millions
Coherus Oncology inc   1.94 $ 117.553  Millions$ 60  Millions
Avanos Medical Inc   1.94 $ 305.600  Millions$ 158  Millions
Intuitive Surgical Inc   1.92 $ 2,717.000  Millions$ 1,413  Millions
Skinhealth Systems Inc   1.91 $ 151.000  Millions$ 79  Millions
Inspire Medical Systems inc   1.91 $ 122.000  Millions$ 64  Millions
Ani Pharmaceuticals Inc  1.91 $ 250.210  Millions$ 131  Millions
Avadel Pharmaceuticals Plc  1.90 $ 15.277  Millions$ 8  Millions
Ultragenyx Pharmaceutical Inc   1.87 $ 76.728  Millions$ 41  Millions
Ligand Pharmaceuticals Incorporated  1.86 $ 32.959  Millions$ 18  Millions
Intelligent Bio Solutions Inc   1.85 $ 1.467  Millions$ 1  Millions
Enzo Biochem Inc  1.85 $ 12.276  Millions$ 7  Millions
Staar Surgical Co  1.84 $ 74.319  Millions$ 40  Millions
Cytek Biosciences Inc   1.83 $ 89.319  Millions$ 49  Millions
Biotricity Inc   1.82 $ 3.407  Millions$ 2  Millions
Aytu Biopharma Inc  1.81 $ 22.000  Millions$ 12  Millions
Procept Biorobotics Corporation  1.81 $ 87.000  Millions$ 48  Millions
Journey Medical Corp  1.80 $ 20.879  Millions$ 12  Millions
Fortress Biotech Inc   1.80 $ 20.879  Millions$ 12  Millions
Haemonetics Corporation  1.79 $ 641.000  Millions$ 358  Millions
Pacific Biosciences Of California Inc   1.78 $ 116.000  Millions$ 65  Millions
Lensar Inc   1.78 $ 27.641  Millions$ 16  Millions
Y mabs Therapeutics inc   1.78 $ 15.000  Millions$ 8  Millions
Yunhong Green Cti Ltd   1.78 $ 14.000  Millions$ 8  Millions
Nephros Inc   1.77 $ 5.000  Millions$ 3  Millions
Utah Medical Products Inc  1.77 $ 15.982  Millions$ 9  Millions
Prophase Labs Inc   1.76 $ 5.592  Millions$ 3  Millions
Sinovac Biotech Ltd  1.76 $ 140.000  Millions$ 80  Millions
Bausch and Lomb Corp  1.74 $ 1,868.000  Millions$ 1,074  Millions
Integra Lifesciences Holdings Corp  1.72 $ 728.466  Millions$ 423  Millions

Date modified: 2026-06-22T16:30:35+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.